Elrexfio Injection, Solution
Product Images NDC 0069-2522

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Elrexfio (NDC 0069-2522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Elranatamab 01)

FDA Label Image

Logo (Elranatamab 02)

FDA Label Image

Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)

Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)
Label for Elrexfio (elranatamab-bcmm) injection, solution, 44 mg/1.1 mL, subcutaneous use. The single-dose vial is produced by Pfizer Laboratories Div Pfizer Inc. The label advises dispensing the accompanying medication guide, storing refrigerated at 2°C to 8°C in the original carton to protect from light, and discarding unused portions. No preservatives are included.*
FDA Label Image

Principal Display Panel – 44 mg/1.1 mL Vial Carton (Elranatamab 04)

Principal Display Panel – 44 mg/1.1 mL Vial Carton (Elranatamab 04)
Packaging label for Elrexfio 44 mg/1.1 mL (40 mg/mL) injection, a subcutaneous solution of elranatamab-bcmm. The label states it is for healthcare provider use only, with one single-dose vial per carton. Manufactured and distributed by Pfizer Inc. The label includes storage instructions, contents, and a barcode for the product.*
FDA Label Image

Principal Display Panel – 76 mg/1.9 mL Vial (Elranatamab 05)

Principal Display Panel – 76 mg/1.9 mL Vial (Elranatamab 05)
Label for Elrexfio 76 mg/1.9 mL injection solution containing elranatamab-bcmm, for subcutaneous use. The single-dose vial label includes storage instructions to refrigerate at 2°C to 8°C and warnings not to freeze or shake. Manufactured by Pfizer Inc.*
FDA Label Image

Principal Display Panel – 76 mg/1.9 mL Vial Carton (Elranatamab 06)

Principal Display Panel – 76 mg/1.9 mL Vial Carton (Elranatamab 06)
Packaging label for Elrexfio (elranatamab-bcmm) injection, solution 76 mg/1.9 mL (40 mg/mL) for subcutaneous injection. The label indicates it is a single-dose vial for use by healthcare providers only, with instructions to discard unused portions. Manufactured by Pfizer Laboratories Division of Pfizer Inc. Information on storage and contents is included, along with a barcode and Pfizer Oncology logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.